149 related articles for article (PubMed ID: 7019720)
21. [Antiaggregation activity of various synthetic prostaglandins].
Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
[No Abstract] [Full Text] [Related]
22. Cardiac prostacyclin release: stimulation by hypoxia and various agents.
Kirstein A
Scand J Haematol Suppl; 1979; 34():105-11. PubMed ID: 384504
[No Abstract] [Full Text] [Related]
23. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206.
Hecker G; König E; Ney P; Schrör K
Prog Clin Biol Res; 1987; 242():317-22. PubMed ID: 2444988
[No Abstract] [Full Text] [Related]
24. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
25. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
Bult H; Herman AG
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
[No Abstract] [Full Text] [Related]
26. Prostacyclin is a circulating hormone.
Moncada S; Korbut R; Bunting S; Vane JR
Nature; 1978 Jun; 273(5665):767-8. PubMed ID: 351418
[No Abstract] [Full Text] [Related]
27. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
28. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
29. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
Kindness G; Williamson FB; Long WF
Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
[No Abstract] [Full Text] [Related]
30. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
[No Abstract] [Full Text] [Related]
31. The effect of prostaglandins E1, I2 and F2 alpha on the shape and phosphatidylinositol-4,5-bisphosphate metabolism of washed rabbit platelets.
Vickers JD; Kinlough-Rathbone RL; Mustard JF
Thromb Res; 1982 Dec; 28(6):731-40. PubMed ID: 6301091
[No Abstract] [Full Text] [Related]
32. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
Carreras LO; Chamone DA; Vermylen J
Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
[No Abstract] [Full Text] [Related]
33. An improved method for washing of human platelets with prostacyclin.
Radomski M; Moncada S
Thromb Res; 1983 May; 30(4):383-9. PubMed ID: 6351341
[No Abstract] [Full Text] [Related]
34. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
[No Abstract] [Full Text] [Related]
35. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
[No Abstract] [Full Text] [Related]
36. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
Whittle BJ; Hamid S; Lidbury P; Rosam AC
Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
[No Abstract] [Full Text] [Related]
37. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
[No Abstract] [Full Text] [Related]
38. Prostacyclin and its analogues for the therapy of thromboembolic disorders.
Whittle BJ; Moncada S
Adv Exp Med Biol; 1984; 164():193-209. PubMed ID: 6364707
[No Abstract] [Full Text] [Related]
39. Platelet function in experimentally induced pancreatitis in the dog.
Jacobs RM; Murtaugh RJ; Fertel RH
Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
[TBL] [Abstract][Full Text] [Related]
40. Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP).
Westwick J; Webb H
Thromb Res; 1978 Jun; 12(6):973-8. PubMed ID: 358484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
